April 25, 2018 / 4:03 PM / 3 months ago

BRIEF-Genkyotex Cash And Cash Equivalents At 12.5 Million Euros

April 25 (Reuters) - GENKYOTEX SA:

* CASH AND CASH EQUIVALENTS OF €12.5 MILLION AS OF MARCH 31ST, 2018, IN LINE WITH EXPECTATIONS

* COMPANY NOW EXPECTS INTERIM RESULTS FROM PHASE 2 TRIAL OF GKT831 IN PRIMARY BILIARY CHOLANGITIS FALL 2018 AND FINAL RESULTS IN H1 2019

* BASED ON ANTICIPATED LOWER OPERATING EXPENSES, WE EXPECT COMPANY'S CASH RUNWAY TO NOW EXTEND TO Q3 2019 Source text : bit.ly/2HrtpSt Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below